Monthly Treatment Costs: Wegovy vs Mounjaro Breakdown
Wegovy vs Mounjaro Price Per Month: The Complete Comparison
Understanding Wegovy price per month requires comparing both the medication costs and the underlying mechanisms that differentiate these two prescription-only medicines. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, which targets both GLP-1 and GIP receptors for a dual-hormone approach. This fundamental difference impacts dosing schedules, storage requirements, and ultimately your monthly investment in weight management treatment. The Wegovy price per month varies significantly through the dose escalation period, starting at £79.99 for the initial 0.25mg dose and reaching £209.99 for the maintenance 2.4mg dose.
Both medications require mandatory dose escalation protocols, but Wegovy follows a 5-dose schedule (0.25mg to 2.4mg) whilst Mounjaro uses 6 doses (2.5mg to 15mg). This affects the Wegovy price per month calculation differently than Mounjaro's progression, as patients typically reach Wegovy's maintenance dose by week 17, whereas Mounjaro's escalation extends longer. Your prescriber will determine which medication suits your clinical profile, but having both options available from EverydayMeds ensures you can access either treatment through our streamlined online assessment process.
Exact Wegovy Price Per Month During Each Treatment Phase
The Wegovy price per month follows a structured escalation reflecting the medication's dose-increase protocol mandated by clinical guidelines. Month one costs £79.99 for the 0.25mg starter dose, followed by £94.99 for 0.5mg in weeks 5-8, then £99.99 for the 1mg dose during weeks 9-12. The pre-maintenance 1.7mg dose costs £139.99 per month, before reaching the full maintenance dose of 2.4mg at £209.99 monthly from week 17 onwards. These prices include the application of discount codes FIRST40 for new customers or DOSE25 for returning patients, applied automatically at checkout.
Bundle options can provide convenience for planning your Wegovy price per month budget over multiple months. Our Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99 and covers your first three months of treatment, whilst the Ultimate Stability Trio provides three months of maintenance 2.4mg doses for £649.99. The Getting Started bundles like the Intro Duo (0.25mg & 0.5mg) at £169.99 help patients secure their initial two months of treatment with fewer ordering requirements and assured cold-chain delivery scheduling.
Clinical Evidence Behind Wegovy Price Per Month Value
The Wegovy price per month reflects the medication's robust clinical evidence from the STEP trial programme, where participants achieved significant weight management results alongside reduced-calorie diet and increased physical activity. In STEP 1, patients taking Wegovy experienced approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, whilst STEP 2 demonstrated clinically studied weight loss in patients with type 2 diabetes. The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events, providing additional clinical value beyond weight management.
When evaluating Wegovy price per month against treatment outcomes, the STEP 5 trial demonstrated sustained clinically studied weight loss at two years, indicating long-term effectiveness. However, the STEP 1 extension revealed that patients regained approximately two-thirds of weight lost within one year of stopping treatment, emphasising that weight management represents a long-term commitment rather than a short-term intervention.
How Wegovy Works to Justify Monthly Investment Costs
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone your body produces after eating. This mechanism may help reduce appetite and promote feelings of satiety after smaller meals, potentially supporting weight management when combined with lifestyle modifications. The medication works on brain appetite centres and may reduce food cravings, though individual responses can vary significantly. Understanding this mechanism helps contextualise the Wegovy price per month as an investment in a scientifically-backed approach to appetite regulation. The once-weekly injection schedule using Novo Nordisk's FlexTouch pen system provides consistent medication levels throughout the week, supporting adherence to your prescribed treatment plan.
Streamlined Ordering Process for Monthly Wegovy Supply
Accessing your monthly Wegovy supply through EverydayMeds begins with our 3-minute online clinical assessment, designed to gather essential information for prescriber review. Our qualified prescribers evaluate your submission within 3 working days under standard service, or within 24 hours using our express review option for faster treatment initiation. Once approved, your Wegovy prescription ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. This streamlined process eliminates traditional pharmacy queues whilst ensuring full compliance with MHRA regulations for prescription-only medicines. The entire system operates under our GPhC registration (#9012878), providing regulatory assurance for your monthly Wegovy orders.
Storage Requirements Affecting Wegovy Monthly Costs
Wegovy's storage profile offers practical advantages that can influence your monthly treatment planning and costs. The medication requires refrigeration at 2-8°C before first use but can remain stable at room temperature below 30°C for up to 6 weeks once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. This extended stability supports travel, reduces wastage from temperature excursions, and provides flexibility for patients with varying schedules. The FlexTouch pen delivery system eliminates mixing requirements and includes dose escalation safety features to prevent accidental overdosing. Understanding these storage benefits helps justify the Wegovy price per month investment by reducing potential medication wastage and supporting consistent treatment adherence.
Wegovy vs Mounjaro Monthly Cost Analysis for UK Patients
Comparing Wegovy price per month against Mounjaro requires understanding both medications' distinct escalation schedules and maintenance phases. Wegovy's 5-dose protocol reaches maintenance by week 17, whilst Mounjaro's 6-dose system extends the escalation period longer, affecting your monthly budgeting differently. Both medications require prescription-only access and clinical monitoring, but their storage profiles differ significantly with Wegovy offering extended room temperature stability. Neither medication should be considered superior without clinical context, as your prescriber must evaluate which mechanism suits your individual health profile.
The choice between Wegovy and Mounjaro often depends on clinical factors beyond monthly costs, including your response to GLP-1 versus dual GIP/GLP-1 receptor targeting. EverydayMeds stocks both medications to provide prescriber flexibility and patient choice within one trusted pharmacy relationship. This dual availability eliminates the need to research multiple pharmacies and ensures consistent service quality regardless of which treatment your prescriber recommends for your weight management journey.
Secure Your Monthly Wegovy Supply with Confidence
Ready to begin comparing Wegovy price per month options with professional clinical support? Visit our weight loss collection at https://everydaymeds.co.uk/collections/weight-loss to access both Wegovy and Mounjaro through our clinically-supervised service. New customers receive code FIRST40 whilst returning patients use DOSE25, both applied automatically at checkout to reach our listed prices. Our express prescriber review ensures you can begin treatment within 24 hours of assessment completion, supported by next-day cold-chain delivery to maintain medication integrity. Whether you choose Wegovy or Mounjaro, our clinical team provides ongoing support throughout your weight management journey. The combination of competitive pricing, clinical expertise, and regulatory compliance through GPhC registration (#9012878) ensures you receive genuine prescription-only medicines with full professional support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
